Stroke is one of the most common causes of morbidity and mortality worldwide. Despite significant advances in acute treatment and secondary prevention, primary prevention remains crucial to prevent the first occurrence of stroke and its serious consequences. The “Guideline for the Primary Prevention of Stroke” of the American Heart Association (AHA) and American Stroke Association (ASA) was fundamentally revised in 2024, replacing the previous recommendations from 2014.
Autoren
- Tanja Schliebe
Publikation
- HAUSARZT PRAXIS
- CARDIOVASC
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Update 2025
Hypercholesterolemia
- GPP: from molecular principles to targeted therapy
Therapeutic rationale for targeted IL-36 receptor inhibition
- HFpEF 2025
Precision medicine and phenotypes
- Myelofibrosis
New treatment options for myelofibrosis patients with a high risk of anemia?
- Chronic insomnia in adults: Guideline recommendations
CBT-i as first choice – pharmacotherapy as secondary intervention
- Pulmonary hypertension
PH and lung diseases
- COPD therapy
Drug therapy – Update 2025
- IBDmatters - Synergy effects for IBD pathways